The role of Bacillus Clausii as an adjuvant therapy in Rotavirus diarrhoea in Children.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202502827841363

Enrollment

100

Registered

2025-02-03

Start date

2023-08-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System rotavirus Paediatrics

Interventions

oral rehydration solutionand oral zinc

oral rehydration solution oral zinc in addition to oral Bacillus clausii suspension.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Age between 6 months to 5 years - Children with mild to moderate dehydration - No recent prior probiotic administration of Bacillus Clausii An Adjuvant Therapy In Acute Childhood Diarrhea .

Exclusion criteria

Exclusion criteria: 1.Children whom diagnosed as bacterial diarrhea. 2. Children with chronic diarrhea 3. Children with actue diarrhoea due to systemic illness. 4. Children with severe dehydration

Design outcomes

Primary

Measure	Time frame
assessent of the response to treatment through AssessmentofseverityofdiarrheausingModified VesiKari score ,assessment of degree of dehydration	—

Secondary

Measure	Time frame
and lab tests ABG,serum Na, K, blood urea , serum creatinine, CBC	—

Countries

Egypt

Contacts

Public ContactManal Mahmoud Elkharkhesy

lecturer of pediatrics

manal.mahmoud@med.tanta.edu.eg+201015890407

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026